153 related articles for article (PubMed ID: 17956162)
21. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Bernante P; Pagetta C; Rampin L; Rubello D
Eur J Surg Oncol; 2006 Dec; 32(10):1144-8. PubMed ID: 16872798
[TBL] [Abstract][Full Text] [Related]
22. Papillary thyroid microcarcinoma: a surgical perspective.
Sakorafas GH; Giotakis J; Stafyla V
Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
[TBL] [Abstract][Full Text] [Related]
23. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
24. [Non-incidental papillary microcarcinomas of the thyroid].
Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
[TBL] [Abstract][Full Text] [Related]
25. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
26. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid microcarcinoma: how to diagnose and manage this epidemic?
Soares P; Celestino R; Gaspar da Rocha A; Sobrinho-Simões M
Int J Surg Pathol; 2014 Apr; 22(2):113-9. PubMed ID: 24401191
[TBL] [Abstract][Full Text] [Related]
28. Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.
Pelizzo MR; Boschin IM; Toniato A; Pagetta C; Piotto A; Bernante P; Casara D; Pennelli G; Rubello D
Nucl Med Commun; 2004 Jun; 25(6):547-52. PubMed ID: 15167512
[TBL] [Abstract][Full Text] [Related]
29. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA
J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544
[TBL] [Abstract][Full Text] [Related]
30. Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.
So YK; Son YI; Baek CH; Jeong HS; Chung MK; Ko YH
Ann Surg Oncol; 2012 Mar; 19(3):990-5. PubMed ID: 21879263
[TBL] [Abstract][Full Text] [Related]
31. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
32. Prognostic parameters for recurrence of papillary thyroid microcarcinoma.
Kim TY; Hong SJ; Kim JM; Kim WG; Gong G; Ryu JS; Kim WB; Yun SC; Shong YK
BMC Cancer; 2008 Oct; 8():296. PubMed ID: 18851763
[TBL] [Abstract][Full Text] [Related]
33. Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.
Roh JL; Kim JM; Park CI
Ann Surg Oncol; 2008 Sep; 15(9):2482-6. PubMed ID: 18612697
[TBL] [Abstract][Full Text] [Related]
34. The occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinoma.
Kaliszewski K; Diakowska D; Wojtczak B; Migoń J; Kasprzyk A; Rudnicki J
Medicine (Baltimore); 2019 May; 98(19):e15609. PubMed ID: 31083255
[TBL] [Abstract][Full Text] [Related]
35. Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Koo BS; Lim HS; Lim YC; Yoon YH; Kim YM; Park YH; Rha KS
Ann Surg Oncol; 2010 Apr; 17(4):1101-5. PubMed ID: 20066517
[TBL] [Abstract][Full Text] [Related]
36. [Predictive factors for level VI lymph node metastasis in papillary thyroid microcarcinoma].
Wang Y; Ji QH; Huang CP; Zhu YX; Zhang L
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(24):1899-901. PubMed ID: 19134382
[TBL] [Abstract][Full Text] [Related]
37. Endoplasmic reticulum aminopeptidase 2 is highly expressed in papillary thyroid microcarcinoma with cervical lymph node metastasis.
Kim WY; Lee JB; Kim HY; Woo SU; Son GS; Bae JW
J Cancer Res Ther; 2015; 11(2):443-6. PubMed ID: 26148615
[TBL] [Abstract][Full Text] [Related]
38. Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.
Park VY; Kim EK; Lee HS; Moon HJ; Yoon JH; Kwak JY
Medicine (Baltimore); 2015 Jul; 94(28):e1149. PubMed ID: 26181555
[TBL] [Abstract][Full Text] [Related]
39. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis.
Jeon MJ; Chung MS; Kwon H; Kim M; Park S; Baek JH; Song DE; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JH; Kim WG
Clin Endocrinol (Oxf); 2017 Jun; 86(6):845-851. PubMed ID: 28273370
[TBL] [Abstract][Full Text] [Related]
40. Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas.
Jeon MJ; Kim WG; Choi YM; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Kim TY; Shong YK; Song DE; Kim WB
Thyroid; 2016 Jan; 26(1):161-8. PubMed ID: 26563473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]